NasdaqGM - Nasdaq Real Time Price USD

SS Innovations International Inc. Common Stock (SSII)

11.35

+3.36

+(42.05%)

At close: April 25 at 4:00:00 PM EDT

11.86

+0.51

+(4.49%)

After hours: April 25 at 7:56:31 PM EDT

SS Innovations to Uplist to Nasdaq

FORT LAUDERDALE, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”). Trading on Nasdaq is expected to commence on April 25, 2025, and the Company’s shares will conti

GlobeNewswire 2 days ago

SSII
+42.05%
SS Innovations Achieves Significant Milestones in 2024

The Company’s award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The Company Continues to Build a Strong Foundation for Future Growth FORT LAUDERDALE, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery afforda

GlobeNewswire 26 days ago

SSII
+42.05%
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine. SS Innovations International along with RBGM Medical Express Sales Inc., its Manila

GlobeNewswire 29 days ago

SSII
+42.05%
SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km.The SSi Mantra, India’s first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures. FORT LAUDERDALE, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a dev

GlobeNewswire 30 days ago

SSII
+42.05%
SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025

FORT LAUDERDALE, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its Mobile Tele-Surgical Unit, aimed at improving remote surgical access and healthcare delivery at the Company’s Second Global Multi-Specialty Robotic Surgery Conference (S

GlobeNewswire last month

SSII
+42.05%
SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

FORT LAUDERDALE, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced the launch of its 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025), organized in collaboration with leading medical societies from both national and international platforms

GlobeNewswire last month

SSII
+42.05%
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3

A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes.The world’s first Robotic Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) Telesurgery was performed with a latency of only 40 milliseconds (less than 1/20th of a second).The procedures were performed using the SSi Mantra 3 Surgical Robotic System which was remotely connected from SS Innovations’ headquarters in Gurugram, India to Manipal Hospital in Jaipur, Rajasth

GlobeNewswire 3 months ago

SSII
+42.05%
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

FORT LAUDERDALE, Fla., Dec. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its new independent registered public accounting firm, BDO India LLP (“BDO”), has completed the re-audit of the Company’s consolidated financial statements for the years ended December 3

GlobeNewswire 4 months ago

SSII
+42.05%
India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical roboticsSS Innovations reinforces India's position as a hub for technological innovation in healthcare using the SSi Mantra - Made in India, for the WorldThe SSi Mantra integrates innovative advancements in robotic surgery, offering surgeons enhanced precision and contr

GlobeNewswire 4 months ago

SSII
+42.05%
SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

• SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System.• Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) in Indonesia, a significant achievement in the field of robotic cardiac surgery.• The developed and made-in-India SSi Mantra Surgical Robotic System highlights India’s position

GlobeNewswire 4 months ago

SSII
+42.05%
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

Tim Adams to serve as Independent Board DirectorFORT LAUDERDALE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, is pleased to announce the addition of Mr. Tim Adams to its Board of Directors, where he will serve as an Independent Director. Mr. Adams is a well-known an

GlobeNewswire 6 months ago

SSII
+42.05%
Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System

FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, announced that it has now successfully completed over 2,000 robotic surgeries, primarily in India, using its SSi Mantra Surgical Robotic System (the “SSi Mantra”). The significance of the 2,000 surgeries ex

GlobeNewswire 6 months ago

SSII
+42.05%
SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

FORT LAUDERDALE, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update on its progress and timeline in obtaining U.S. Food and Drug Administration (“FDA”) approvals to market the SSi Mantra Surgical Robotic System (“SSi Mantra”) in the United States. Ear

GlobeNewswire 7 months ago

SSII
+42.05%
SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board

Dr. Moll, founder of Intuitive Surgical, to serve as Vice ChairmanFORT LAUDERDALE, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, is pleased to announce the addition of Dr. Fredric Moll to its Board of Directors, where he will serve as Vice Chairman. Dr. Moll is the f

GlobeNewswire 7 months ago

SSII
+42.05%
SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador FORT LAUDERDALE, Fla. , Sept. 03, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class rob

GlobeNewswire 7 months ago

SSII
+42.05%
SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

FORT LAUDERDALE, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update to its shareholders and the investment community on the status of its audit process and the trading market for its common stock. As previously reported in its Securities and Exchange C

GlobeNewswire 7 months ago

SSII
+42.05%
Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3

New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive DemonstrationFORT LAUDERDALE, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra-3 Surgical R

GlobeNewswire 9 months ago

SSII
+42.05%
SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector

Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made SSi Mantra SSi Mantra integrates cutting edge advancements in robotic surgery, offering surgeons unparalleled precision and control for improved patient outcomesSS Innovations helps reinforce India's position as a global hub for technological innovation in healthcare FORT LAUDERDALE, Fla., July 09, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII),

GlobeNewswire 9 months ago

SSII
+42.05%
SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024

Annual awards celebrate the best of the surgical robotics industry.FORT LAUDERDALE, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, was recently selected as a finalist in the Surgical Robotics Industry Awards 2024 in the “Outstanding Company” category. The Company’s SSi

GlobeNewswire 10 months ago

SSII
+42.05%
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia

FORT LAUDERDALE, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System has received regulatory approval from the Indonesian Ministry of Health for clinical use in the Republic of Indonesia. With more than 279 million

GlobeNewswire 10 months ago

SSII
+42.05%

Performance Overview

Return	SSII	S&P 500 (^GSPC)
YTD	+43.85%	-6.06%
1-Year	+183.75%	+9.44%
3-Year	+183.75%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

SS Innovations International Inc. Common Stock (SSII)

SS Innovations to Uplist to Nasdaq

SS Innovations Achieves Significant Milestones in 2024

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3

SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting

India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System

SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline

SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3

SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector

SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia

Performance Overview